Insolvency Bankruptcy Code with Reference to Medical Insolvency - A Regime

The Insolvency and Bankruptcy Code (IBC), introduced in 2016, was designed to unify and streamline the existing insolvency and bankruptcy laws into a single comprehensive framework. One of the primary goals of the IBC is to safeguard creditors' interests. The Code aimed to address the shortcomings of previous insolvency laws by moving away from the debtor-in-possession model, which was common in the earlier regime. Instead, the IBC established a framework where both creditors and debtors could operate within a structure of equity and fairness, ultimately working to preserve the value of the company. However, the IBC is still evolving and is not without its flaws. In response to the challenges posed by the Covid-19 pandemic, the government has shifted its focus towards protecting businesses. Although the Insolvency and Bankruptcy Code (Amendment) Ordinance, 2020, appears to have been enacted with the intention of shielding companies and promoters from liabilities arising through no fault of their own during the pandemic, the ambiguities within the legislation raise more questions than answers. In fact, this recent ordinance seems to suggest a return to the earlier model, which was detrimental to creditors' interests. This essay seeks to analyze the issues and ambiguities associated with the 2020 Ordinance, with particular attention to its implications for the IBC.